MetaCap

Gilead Sciences Statistics

NASDAQ: GILDHealthcareDrug Manufacturers - GeneralUSD

146.85+2.62 (+1.82%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

Gilead Sciences by the numbers

Gilead Sciences has a market capitalization of $182.09 billion based on 1.24B shares outstanding. With trailing EPS of $-2.65, Gilead Sciences is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 2.1% above its 50-day average and 7.2% above its 200-day average.

Average daily trading volume is 6.02M shares, or about $884.3 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

GILD valuation vs. peer median

GILD compared with the median of 4 peer companies
MetricGILDPeer medianDifference
Market cap$182.09B$48.91B+272%
Forward P/E14.89.6+55%
Dividend yield2.19%1.45%+52%
Avg. volume6.02M3.19M+89%

Peer median across 4 companies: PFE, GSK, OGN, AMRN.

Valuation

Market cap
$182.09B
Price / sales (latest FY)
6.18
EPS (TTM)
$-2.65

Price and trading

Previous close
144.23
Open
145.44
Day range
144.85 – 148.60
52-week range
114.02 – 157.29
52-week change
+25.75%
Beta
—
Volume
4.96M

Dividends and events

Annual dividend
$3.22
Next earnings date
Oct 29, 2026

Additional statistics

Market Cap
182.09B
Forward Pe
14.85
Eps
-2.65
Dividend Yield
2.23%
Dividend Rate
3.22
Week52 High
157.29
Week52 Low
114.02
Avg Volume
6.02M
Shares Outstanding
1.24B
Ma50
143.78
Ma200
136.94
Earnings Date
Oct 29, 2026
Pct From52w High
-6.64%
Pct From52w Low
28.79%

Related